Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Title Grant Type Focus Area Country Application Due Date Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung CancerRelease Date:Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Netherlands, Norway, Portugal, Spain, Swaziland, Sweden, USA, United Kingdom Immunotherapy in High-risk Non-Muscle Invasive Bladder CancerRelease Date:Education Oncology USA Advances in Migraine TreatmentRelease Date:Education Internal Medicine All 2022/2023 Global Obesity ASPIRERelease Date:Research Internal Medicine All Evolving Concepts in Biosimilar Optimization in Inflammatory DiseasesRelease Date:Education Inflammation & Immunology USA Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)Release Date:Education Hospital All Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoringRelease Date:Quality Improvement Hospital USA 2022/2023 Global NASH ASPIRERelease Date:Research Internal Medicine All 2023 Growth Hormone ResearchRelease Date:Research Rare Disease All Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital All Medication Error Reduction Strategies in the Hospital SettingRelease Date:Education Hospital USA 2022/2023 Global Cachexia ASPIRERelease Date:Research Internal Medicine All